全文获取类型
收费全文 | 6713篇 |
免费 | 473篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 91篇 |
儿科学 | 198篇 |
妇产科学 | 179篇 |
基础医学 | 861篇 |
口腔科学 | 425篇 |
临床医学 | 548篇 |
内科学 | 1425篇 |
皮肤病学 | 182篇 |
神经病学 | 687篇 |
特种医学 | 127篇 |
外科学 | 833篇 |
综合类 | 47篇 |
一般理论 | 2篇 |
预防医学 | 702篇 |
眼科学 | 88篇 |
药学 | 480篇 |
中国医学 | 19篇 |
肿瘤学 | 323篇 |
出版年
2023年 | 63篇 |
2022年 | 137篇 |
2021年 | 238篇 |
2020年 | 140篇 |
2019年 | 220篇 |
2018年 | 254篇 |
2017年 | 161篇 |
2016年 | 180篇 |
2015年 | 191篇 |
2014年 | 256篇 |
2013年 | 348篇 |
2012年 | 512篇 |
2011年 | 501篇 |
2010年 | 260篇 |
2009年 | 206篇 |
2008年 | 360篇 |
2007年 | 384篇 |
2006年 | 327篇 |
2005年 | 343篇 |
2004年 | 253篇 |
2003年 | 242篇 |
2002年 | 250篇 |
2001年 | 155篇 |
2000年 | 141篇 |
1999年 | 108篇 |
1998年 | 38篇 |
1997年 | 41篇 |
1996年 | 36篇 |
1995年 | 35篇 |
1994年 | 26篇 |
1993年 | 22篇 |
1992年 | 75篇 |
1991年 | 79篇 |
1990年 | 77篇 |
1989年 | 55篇 |
1988年 | 49篇 |
1987年 | 47篇 |
1986年 | 36篇 |
1985年 | 39篇 |
1984年 | 30篇 |
1983年 | 42篇 |
1982年 | 26篇 |
1981年 | 20篇 |
1979年 | 19篇 |
1978年 | 15篇 |
1977年 | 18篇 |
1976年 | 15篇 |
1974年 | 15篇 |
1972年 | 16篇 |
1970年 | 15篇 |
排序方式: 共有7217条查询结果,搜索用时 15 毫秒
51.
Quinolinic acid (QUIN), a product of tryptophan metabolism by the kynurenine pathway, produces excitotoxicity by activation of NMDA receptors. Focal injections of QUIN can deplete the biochemical markers for dopaminergic, cholinergic, gabaergic, enkephalinergic and NADPH diaphorase neurons, which differ in their sensitivity to its neurotoxic action. This effect of QUIN differs from that of other NMDA receptor agonists in terms of its dependency on the afferent glutamatergic input and its sensitivity to the receptor antagonists. The enzymatic pathway yielding QUIN produces metabolites that inhibit QUIN-induced neurotoxicity. The most active of these metabolites, kynurenic acid (KYNA), blocks NMDA and non-NMDA receptor activity. Treatment with kynurenine hydroxylase and kynureinase inhibitors increases levels of endogenous KYNA in the brain and protects against QUIN-induced neurotoxicity. Other neuroprotective strategies involve reduction in QUIN synthesis from its immediate precursor, or endogenous synthesis of 7-chloro-kynurenic acid, a NMDA antagonist, from its halogenated precursor. Several other tryptophan metabolites--quinaldic acid, hydroxyquinaldic acid and picolinic acid--also inhibit excitotoxic damage but their presence in the brain is uncertain. Picolinic acid is of interest since it inhibits excitotoxic but not neuroexcitatory responses. The mechanism of its anti-excitotoxic action is unclear but might involve zinc chelation. Neurotoxic actions of QUIN are modulated by nitric oxide (NO). Treatment with inhibitors of NO synthase can augment QUIN toxicity in some models of excitotoxicity suggesting a neuroprotective potential of endogenous NO. In recent studies, certain nitroso compounds which could be NO donors, have been reported to reduce the NMDA receptor-mediated neurotoxicity. The existence of endogenous compounds which inhibit excitotoxicity provides a basis for future development of novel and effective neuroprotectants. 相似文献
52.
Ezra R Lowe Andrew C Everett Anthony J Lee Miranda Lau Anwar Y Dunbar Vladimir Berka Ah-Lim Tsai Yoichi Osawa 《Drug metabolism and disposition》2005,33(1):131-138
Smoking causes a dysfunction in endothelial nitric-oxide synthase (eNOS), which is ameliorated, in part, by administration of tetrahydrobiopterin (BH(4)). The exact mechanism by which the nitric oxide deficit occurs is unknown. We have previously shown that aqueous extracts of chemicals in cigarettes (CE) cause the suicide inactivation of neuronal NO synthase (nNOS) by interacting at the substrate-binding site. In the current study, we have found that CE directly inactivates eNOS by a process that is not affected by the natural substrate l-arginine and is distinct from the mechanism of inactivation of nNOS. We discovered that CE causes a time-, concentration-, and NADPH-dependent inactivation of eNOS in an in vitro system containing the purified enzyme, indicating a metabolic component to the inactivation. The CE-treated eNOS but not nNOS was nearly fully reactivated upon incubation with excess BH(4), suggesting that BH(4) depletion is a potential mechanism of inactivation. Moreover, in the presence of CE, eNOS catalyzed the oxidation of BH(4) to dihydrobiopterin and biopterin by a process attenuated by high concentrations of superoxide dismutase but not catalase. We speculate that a redox active component in CE, perhaps a quinone compound, causes oxidative uncoupling of eNOS to form superoxide, which in turn oxidizes BH(4). The discovery of a direct inactivation of eNOS by a compound(s) present in tobacco provides a basis not only for further study of the mechanisms responsible for the biological effects of tobacco but also a search for a potentially novel inactivator of eNOS. 相似文献
53.
54.
Filipa Alves da Costa Jos Pedro Guerreiro Magda Nunes de Melo Ana da Costa Miranda Ana Paula Martins Jos Garo Brenda Madureira 《The International journal of pharmacy practice》2005,13(3):205-211
Objective Poor compliance to antihypertensive medications has been identified as a primary cause of uncontrolled blood pressure (BP), with consequent increases in hypertension‐related morbidity and mortality. Therefore, any measure known to improve compliance should be encouraged. This study assessed the impact of reminder cards on compliance to antihypertensive therapy. Method A field trial was undertaken in pharmacies located in the districts of Lisbon and Porto. Eligible participants comprised those aged 30–74 years, prescribed an angiotensin‐converting enzyme inhibitor (ACEI) in monotherapy, and taken on a once‐daily regimen. Patients were allocated to control group (CG) or intervention group (IG), the latter being provided with a reminder card, an alarm‐type device due to remind the patient of the time to take his medication. Patients were monitored monthly during 3 months for compliance and blood pressure control. Key findings Seventy‐one patients participated in the study (intervention: 35; control group: 36). Compliance was similar between the groups in the first 2 months of follow‐up (97.1% IG vs 94.9% CG at first follow‐up and 97.5% IG vs 94.2% CG at second follow‐up) and higher in the intervention group at the end of the study (97.3% IG vs 87.3% CG; P = 0.011). There were no mean blood pressure differences between compliant and non‐compliant subjects at the end of the study (P value for differences in systolic BP (Psyst) = 0.580; and P value for differences in diastolic BP (Pdlast) = 0.175). Conclusion This small‐scale study indicates a possible positive impact on patients' compliance resulting from the use of reminder cards. However, this needs confirming in larger scale studies with longer monitoring periods. 相似文献
55.
Miranda Leontowitsch Fiona Stevenson Irwin Nazareth Catherine Duggan 《The International journal of pharmacy practice》2005,13(4):273-280
Objectives To assess the feasibility and acceptability of concordance in pharmacy practice through examination of communication between customers and pharmacists in two community pharmacies in consultations for over‐the‐counter medicines. Method A qualitative pilot study involving data drawn from six sources: audiotaped training session with all the pharmacists involved, observational field work in the pharmacies, audiotaped consultations with pharmacists and customers, debriefing interviews with pharmacists after the consultation, and semi‐structured interviews with customers a few days after their consultation. Setting Two community pharmacies that concentrate their services on medicine advice and dispensing, one in a deprived inner‐city area, the other in a more affluent suburban area of London. Key findings The pharmacists developed a personal understanding of concordance which informed their practice. Customers reported a high level of satisfaction with services they received from the respective pharmacists. Their accounts of the consultations verified the pharmacists' patient‐centredness in their day‐to‐day practice. Conclusion The implementation of a concordance model was possible through the development of a personalised, patient‐centred model which drew on the model of concordance but was adapted in accordance with both structural constraints as well as the personal style of the pharmacists involved. 相似文献
56.
Andra Araujo Brando Weimar Kunz Sebba Barroso Audes Feitosa Eduardo Costa Duarte Barbosa Roberto Dischinger Miranda Priscila Valverde de Oliveira Vitorino Roberto Pozzan Lucio Paulo Ribeiro Abraham Epelman Giovanni Alves Saraiva Fabio Serra Silveira Antnio Almeida Braga Marco Mota Gomes 《Arquivos brasileiros de cardiologia》2022,119(2):353
57.
Ana Luísa Soares de Miranda Bruno Cesar Antunes Joo Carlos Minozzo Sabrina de Almeida Lima Ana Flvia Machado Botelho Marco Túlio Gomes Campos Carlos Delfin Chvez-Olrtegui Benito Soto-Blanco 《Toxins》2022,14(5)
Bites of brown spiders (Loxosceles spp.) are responsible for dermonecrotic lesions and potentially systemic envenoming that can lead to death. The only effective therapy is the use of the antivenom, usually produced in horses. However, little is known about the consequences of the systematic use of the Loxosceles venom and adjuvants and of the bleedings on antivenom-producing horses. Thus, the aim of this study was to evaluate the clinical changes in horses in their first immunization protocol for Loxosceles antivenom production. Eleven healthy horses, never immunized, were evaluated in three different periods: T0 (before immunization); T1 (after their first venom immunization); and T2 (after their first bleeding). Horses were clinically evaluated, sampled for blood, and underwent electrocardiographic (ECG) recordings. Several suppurated subcutaneous abscesses occurred due to the use of Freund’s adjuvants and thrombophlebitis due to systematic venipunctures for the bleeding procedures. ECG showed arrhythmias in few horses in T2, such as an increase in T and R waves. In summary, the immunization protocol impacted on horses’ health, especially after bleeding for antivenom procurement. 相似文献
58.
Eline Lima Borges Gilmara Lopes Amorim Marina Barcelos de Miranda Flaviano dos Santos Martins Antnio Carlos Martins Guedes Kinulpe Honorato Sampaio Josimare Aparecida Otoni Spira Lucíola da Silva Barcelos 《Acta cirúrgica brasileira / Sociedade Brasileira para Desenvolvimento Pesquisa em Cirurgia》2022,37(3)
59.
Jesus C. Fabregas Kristen E. Riley Jeannine M. Brant Thomas J. George E. John Orav Miranda B. Lam 《Journal of gastrointestinal oncology.》2022,13(3):1204
BackgroundPancreatic cancer disparities have been described. However, it is unknown if they contribute to a late diagnosis and survival of patients with metastatic disease. Identifying their role is important as it will open the door for interventions. We hypothesize that social determinants of health (SDH) such as income, education, race, and insurance status impact (I) stage of diagnosis of PC (Stage IV vs. other stages), and (II) overall survival (OS) in Stage IV patients.MethodsUsing the National Cancer Database, we evaluated a primary outcome of diagnosis of Stage IV PC and a secondary outcome of OS. Primary predictors included race, income, education, and insurance. Covariates included age, sex and Charlson-Deyo comorbidity score. Univariate, multivariable logistic regression models evaluated risk of a late diagnosis. Univariate, multivariable Cox proportional hazards model examined OS. 95% confidence intervals were used.Results230,877 patients were included, median age of 68 years (SD 12.1). In univariate analysis, a better education, higher income, and insurance decreased the odds of Stage IV PC, while Black race increased it. In multivariable analysis, education [>93% high-school completion (HSC) vs. <82.4%, OR 0.96 (0.93–0.99)] and insurance [private vs. no, OR 0.72 (0.67–0.74)] significantly decreased the risk of a late diagnosis, whereas Black race increased the odds [vs. White, OR 1.09 (1.07–1.12)]. In univariate Cox analysis, having a higher income, insurance and better education improved OS, while Black race worsened it. In multivariable Cox, higher income [>$63,333 (vs. <$40,277), HR 0.87 (0.85–0.89)] and insurance [private vs. no, HR 0.77 (0.74–0.79)] improved OS.ConclusionsSDH impacted the continuum of care for patients with advanced pancreatic cancer, including stage at diagnosis and overall survival. 相似文献
60.
Elma Izze da Silva Magalhes Bianca Rodrigues de Oliveira Lívia Carolina Sobrinho Rudakoff Vitria Abreu de Carvalho Poliana Cristina de Almeida Fonseca Viola Soraia Pinheiro Machado Arruda Carolina Abreu de Carvalho Carla Cristine Nascimento da Silva Coelho Maylla Luanna Barbosa Martins Bragana Heloisa Bettiol Marco Antnio Barbieri Viviane Cunha Cardoso Alcione Miranda dos Santos Renata Bertazzi Levy Antnio Augusto Moura da Silva 《Nutrients》2022,14(15)
Longitudinal studies evaluating the relationship between UPF consumption and the incidence of Metabolic Syndrome (MetS) and its components are still scarce. This study aimed to evaluate the effect of UPF consumption on the incidence of MetS and its components in adults. A prospective study was conducted with 896 participants from the 1978/79 Ribeirão Preto cohort, São Paulo, Brazil. UPF consumption was evaluated in %kcal and %g at ages 23–25 years. Incidence of MetS and its components were estimated at ages 37–39 years, according to the Joint Interim Statement criteria. Poisson regression was used to assess associations, and interactions with sex were investigated. UPF consumption had no association with MetS (%kcal Adjusted PR: 1.00; 95% CI: 0.99–1.01; %g Adjusted PR: 1.00; 95% CI: 0.99–1.01). However, women with higher UPF consumption, in %kcal and %g, had a higher risk of abdominal obesity (%kcal: p = 0.030; %g: p = 0.003); and women with higher UPF consumption, in %g, had a higher risk of low HDL-cholesterol (p = 0.041). For the other components of MetS, no significant associations were observed in either sex. These findings suggest evidence of no association between UPF consumption and MetS; however, consumption of UPF was associated with increased WC and low HDL-c, but only in women. 相似文献